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Hip fracture treatment in Norway
DeviatiOn fROm eviDenCe- BaseD tReatment guiDelines: Data 
fROm the nORwegian hip fRaCtuRe RegisteR, 2014 tO 2018
aims
The aim of this study was to describe variation in hip fracture treatment in Norway ex-
pressed as adherence to international and national evidence- based treatment guidelines, 
to study factors influencing deviation from guidelines, and to analyze consequences of 
non- adherence.
methods
International and national guidelines were identified and treatment recommendations ex-
tracted. All 43 hospitals routinely treating hip fractures in Norway were characterized. From 
the Norwegian Hip Fracture Register (NHFR), hip fracture patients aged > 65 years and op-
erated in the period January 2014 to December 2018 for fractures with conclusive treatment 
guidelines were included (n = 29,613: femoral neck fractures (n = 21,325), stable trochanter-
ic fractures (n = 5,546), inter- and subtrochanteric fractures (n = 2,742)). Adherence to treat-
ment recommendations and a composite indicator of best practice were analyzed. Patient 
survival and reoperations were evaluated for each recommendation.
results
Median age of the patients was 84 (IQR 77 to 89) years and 69% (20,427/29,613) were wom-
en. Overall, 79% (23,390/29,613) were treated within 48 hours, and 80% (23,635/29,613) 
by a surgeon with more than three years’ experience. Adherence to guidelines varied sub-
stantially but was markedly better in 2018 than in 2014. Having a dedicated hip fracture unit 
(OR 1.06, 95%CI 1.01 to 1.11) and a hospital hip fracture programme (OR 1.16, 95% CI 1.06 
to 1.27) increased the probability of treatment according to best practice. Surgery after 48 
hours increased one- year mortality significantly (OR 1.13, 95% CI 1.05 to 1.22; p = 0.001). 
Alternative treatment to arthroplasty for displaced femoral neck fractures (FNFs) increased 
mortality after 30 days (OR 1.29, 95% CI 1.03 to 1.62)) and one year (OR 1.45, 95% CI 1.22 
to 1.72), and also increased the number of reoperations (OR 4.61, 95% CI 3.73 to 5.71). An 
uncemented stem increased the risk of reoperation significantly (OR 1.23, 95% CI 1.02 to 
1.48; p = 0.030).
Conclusion
Our study demonstrates a substantial variation between hospitals in adherence to evidence- 
based guidelines for treatment of hip fractures in Norway. Non- adherence can be ascribed to 
in- hospital factors. Poor adherence has significant negative consequences for patients in the 
form of increased mortality rates at 30 and 365 days post- treatment and in reoperation rates.
Cite this article: Bone Joint Open 2020;1-10:644–653.
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Introduction
hip fractures in older people represent a 
devastating injury for the individual, and 
treatment is followed by elevated mortality, 
reduced quality of life and disability.1 surgery 
is the only effective treatment, and with the 
increasing longevity of the population hip 
fractures represent a steadily growing and 
substantial burden for hospitals and social 
services in our societies.2
the concept of variation in health 
care treatment was pioneered by John 
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wennberg.3 annual reports from the norwegian hip 
fracture Register (nhfR) have shown significant varia-
tions in the treatment of hip fractures in norway.4 we 
know that patient preferences can affect variation.3 
however, for a surgical emergency such as a hip frac-
ture, patients have little or no influence on the choice of 
treatment. unwarranted variation in hip fracture treat-
ment, therefore, depends mostly on the preference of 
the provider (surgeon and hospital). treatment guide-
lines have been introduced to give patients the best 
evidence- based treatment, thereby reducing unwar-
ranted variation.5-9 guidelines are also tools to reduce 
inequity by providing care of equal quality.
the main aim of this paper was, in a national setting, 
to describe compliance with international and national 
treatment guidelines and variation in hip fracture treat-
ment based on data from the nhfR. further aims are 
to analyze relevant factors explaining deviation from 
the guidelines and to determine consequences of 
non- adherence.
methods
The Norwegian Hip Fracture register. this is a population- 
based (5.3 million inhabitants in 2018) national prospec-
tive study based on data from the nhfR. the term "hip 
fracture" denotes patients with femoral neck fractures 
(fnfs: iCD10 code s72.0), trochanteric (iCD10 code 
s72.1) and subtrochanteric (iCD10 code s72.2) fractures. 
the nhfR has collected data on all hip fracture patients 
admitted to hospitals in norway since 2005. the nhfR 
receives a form with information on patients, primary op-
erations, and subsequent reoperations. information on 
patients receiving total hip arthroplasty (tha) is primarily 
registered in the norwegian arthroplasty Register (naR) 
and subsequently imported to the nhfR.10
Completeness of reporting to the nhfR is evaluated 
regularly by comparing registry data with the national 
administrative database (norwegian patient Registry) 
operated by the norwegian Directorate of health. 
Completeness in 2015 to 2016 was 88.2% for osteosyn-
thesis, 94.5% for hemiarthroplasties, and 87.8% for total 
hip arthroplasties.4
Data from all patients registered with a hip fracture 
in the nhfR in the five- year period (January 2014 to 
December 2018) admitted to all 43 hospitals in norway 
routinely treating hip fractures were included. Data on 
patient characteristics (age, sex, american society of 
anesthesiologists grade11 ), fracture type, and treatment 
information (time from injury to surgery, type of treat-
ment, experience level of the surgeon, and reoperations) 
were extracted. information on time from injury to oper-
ation, fracture type, and experience level of the surgeon 
were unavailable for hip fracture patients treated with 
tha, since this is not recorded in the naR.
Follow-up. the patients were followed in the nhfR un-
til time of reoperation. patients without reoperations 
were censored at time of death or on 31 December 2019. 
Data on death was provided to nhfR by the norwegian 
national population Register.
Characteristics of Norwegian acute care hospitals/hospital 
trusts. we performed an online survey of the characteris-
tics of all 43 hospitals (23 hospital trusts) in norway that 
routinely treat hip fracture patients. the hospitals varied 
from small community hospitals with a catchment area 
of fewer than 30,000 inhabitants to large regional and 
university hospitals.12 information was collected on the 
organization of hip fracture care, presence of hospital 
treatment policies/guidelines, dedicated unit for hip frac-
ture patients, interdisciplinary care including an orthog-
eriatric unit, number of beds in the orthopaedic ward(s), 
number of orthopaedic consultants and specialist regis-
trars/residents, and whether the hospital had 24/7 service 
for hip fracture patients. we ranked the hospitals by treat-
ment volume (low to high) and then divided them into 
four volume groups with an equal number of hospitals 
in each group.
Evidence-based hip fracture guidelines. guidelines were 
identified from the guidelines international network 
(gin),13 using the search terms “hip fracture” and “hip 
fracture treatment”. we also searched for evidence- based 
guidelines in BmJ Best practice and pubmed. we identi-
fied six relevant guidelines of high quality. we excluded 
a finnish and a german guideline published in their re-
spective native languages. we also added a consensus- 
based norwegian guideline.5,14
from international guidelines6-9 we extracted treat-
ment recommendations. they largely coincide with the 
norwegian interdisciplinary guideline, which is based on 
the critical literature review and evidence base published 
by national institute for health and Care excellence 
(niCe) in the uK.9 three of the five guidelines (american 
academy of Orthopaedic surgeons (aaOs), scottish 
intercollegiate guidelines network (sign), norwegian 
Orthopaedic association (nOf)) address hip fracture 
treatment in the elderly. the guideline recommenda-
tions are summarized in table  i, which also outlines 
treatment- related and outcome variables where the 
nhfR could provide information. guideline summa-
ries were extracted by two experienced orthopaedic 
surgeons (CK, J- eg).
Recommendations independent of type of fracture 
included data on the time of treatment within 48 hours 
after injury and on surgeon competence, in the nhfR 
defined as more than three years of experience with 
fracture surgery. fracture type- dependent treatment 
recommendations included treatment of undisplaced 
(garden types 1 and 215) femoral neck fractures (fnfs) 
with screw fixation (two or three screws or pins), treat-
ment of displaced fnfs (garden types 3 and 4) with 
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Variable SIGN 20099 NICE 20117 aaOS 20148 aNZ 20146 NOF 20185,14 recommendations and outcomes
Fracture type 
independent
experienced surgeon + + n/a + + + ↓ReOp*
timing of surgery same or next day < 24 h < 48 h same or next day < 24 h < 48 h ↓mORt,* ↑pROm*
< 48 h Daytime
Fracture type dependent
Femoral neck
garden15 1 to 2 
(undisplaced)
screw fixation + n/a + n/a + + ↓lOs, ↓mORt,* ↑pROm*
garden 3 to 4 (displaced)
arthroplasty + + + + + + ↓mORt
Cemented stem + + + + + + ↓ReOp,* ↑pROm*
Trochanteric
aO/Ota16 a1
sliding hip screw + + = = + + ↓mORt,* ↓ReOp,* ↓lOs, 
↓Ot
aO/Ota a2
sliding hip screw + + = = = =
intramedullary nail = = = = = =
Intertrochanteric
aO/Ota a3 incl reverse 
oblique
intramedullary nail + n/a + + + + ↓ReOp*
Subtrochanteric
intramedullary nail + + + + + + ↓ReOp*
*Data available in the nhfR.
+, positive effect; =, equipoise; aaOs, american academy of Ortopaedic surgeons; anZ, australian and new Zealand hip fracture Registry; lOs, length of 
stay; mORt, mortality; n/a, not applicable; niCe, national institute of Care of excellence; nOf, norwegian Orthopaedic association; Ot, operating time; 
Ota, Orthopaedic trauma association; pROm, patient Related Outcome measure; ReOp, reoperations; sign, scottish intercollegiate guidelines network.
arthroplasty (hemi- or total hip arthroplasty) and use of 
a cemented stem.
for trochanteric fractures type aO/Orthopaedic 
trauma association (aO/Ota) a1,16 the guidelines recom-
mend a sliding hip screw (shs) rather than an intramed-
ullary nail (imn). for intertrochanteric fractures, type 
aO/Ota a3, and subtrochanteric fractures, the guidelines 
recommend imn. for trochanteric fractures, type aO/
Ota a2, there is equipoise between shs and imn. these 
fractures were therefore not included in the analysis.
we estimated the proportion of patients receiving treat-
ment fulfilling the guideline recommendations described 
in table i, i.e. treatment within 48 hours; y a surgeon with 
more than three years’ of experience; and using fracture- 
specific recommended treatment. this composite best 
practice indicator, reflecting and summarizing adherence 
to guideline recommendations, was calculated for each 
fracture- specific group. we also estimated best practice 
for all hip fractures as a group, i.e. practice that fulfilled 
the guideline criteria for all fracture types.
the nhfR contained data on 41,699 patients treated 
for a hip fracture in the five- year period between January 
2014 and December 2018 (figure  1). we excluded in 
sequential order patients with pathological fractures 
(treatment based on surgeon discretion), patients 
younger than 65 years (the focus was on elderly 
patients), patients with asa grade 5 (moribund patients 
at operation), or with missing information on asa grade. 
similarly, patients with fracture types with equal recom-
mendations in the guidelines (basocervical fractures and 
multifragmented trochanteric fractures, type aO/Ota 
a2), combined fracture types and those in whom fracture 
type was missing were excluded. subsequently, 29,613 
patients were included in the study: 21,325 fnf, 5,546 
trochanteric and 2,742 sub- or intertrochanteric fractures 
(figure 1). we included 20,427 women and 9,186 men, 
with median age 84 years (interquartile range (iQR) 78 
to 89) and 83 years (iQR 75 to 88) respectively. patient 
characteristics and fracture types are outlined in table ii.
Statistical analysis. the analysis was performed using 
sas/stat for windows v. 7.1 (sas institute, Cary, north 
Carolina, usa). Continuous variables are presented as 
medians and ranges for patients and hospital charac-
teristics. treatment distribution is presented in numbers 
vOl. 1, nO. 10, OCtOBeR 2020
HIP FRACTURE TREATMENT IN NORWAY 647
Fig. 1
patient selection- study population. Ota, Orthopaedic trauma association; asa, american society of anesthesiologists.











Surgeon experience in fracture surgery
< 3 years 4,686 (15.8)
> 3 years 23,635 (79.8)
missing 1,292 (4.4)
Time of surgery after injury
< 48 hours 23,390 (79.0)
> 48 hours 4,931 (16.6)
missing 1,292 (4.4)
Fracture type
undisplaced femoral neck (garden 1 to 2) 4,336 (14.6)
Displaced femoral neck (garden 3 to 4) 16,989 (57.4)
trochanteric aO/Ota a1 5,546 (18.7)
intertrochanteric aO/Ota a3 879 (3.0)
subtrochanteric 1,863 (6.3)
asa, american society of anaesthesiologists; iQR, interquartile range; 
Ota, Orthopaedic trauma association.
and percentages. adherence to guideline recommenda-
tions was calculated as a mean of annual proportions of 
patients treated according to the recommendations de-
scribed. this was performed for each hospital over the 
study period and adjusted for age and sex. we used logis-
tic regression (lR) models to measure the effect of the 
predictors of adherence and results are presented as odds 
ratios (ORs). all analyses were adjusted for age, sex, and 
asa class. for all lR analyses, a 95% confidence interval 
(Ci) was calculated and p- values below 0.05 were consid-
ered statistically significant.
Ethics, funding and conflict of interest. the project was 
approved by the northern norway Regional Committee 
for medical and health Research ethics and was exempt-
ed from the duty of confidentiality (ReK 2018/1955). a 
data protection integrity assessment was compiled ac-
cording to the eu general Data protection Regulation 
(gDpR). the project was funded by the northern norway 
Regional health authority (hnf1482-19). no competing 
interests were declared.
the nhfR is authorized by the norwegian Data 
protection authority to collect and store data on hip 
fracture patients (authorisation issued 3 January 2005; 
reference number 2004/1658 to 2 sve/-). the nhfR 
required patients to sign a written, informed consent 
declaration, and when unable to understand or sign, 
a family member could sign the consent form on their 
behalf. the nhfR is financed by the western norway 
Regional health authority.
results
Patient and treatment characteristics. Overall, two- thirds 
of the patients had severe comorbidity (asa class 3 to 4; n 
= 19,682). a majority of the patients were treated within 
48 hours of injury and by an experienced surgeon (79%; 
n = 23,390). fnfs were most prevalent (72%; n = 21,325). 
fracture treatment is outlined in table iii. most (86%; n 
= 3,747) undisplaced fnfs were treated with screw fixa-
tion, whereas almost all (96%; n = 16,219) displaced fnfs 
were treated with arthroplasty. in all, 68% of trochanteric 
fractures received shs (n = 3783) while imn was used in 
76% (n = 2,084) of inter- and subtrochanteric fractures.
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Table III. treatment distribution in 29,613 patients with a hip fracture.
Category, n (%) Total Screw fixation arthroplasty SHS ImN Other
undisplaced fnf (garden 1 to 2) 4,336 3,747 (86.4) 463 (10.7) 90 (2.1) 11 (0.3) 25 (0.6)
Displaced fnf (garden 3 to 4) 16,989 605 (3.6) 16,219 (95.5) 76 (0.4) 20 (0.1) 69 (0.4)
trochanteric fracture aO/Ota a1 5,546 4 ( < 0.1) 10 (0.2) 3,783 (68.2) 1,651 (29.8) 98 (1.8)
intertrochanteric fracture aO/Ota a3 1,863 3 (0.2) 1 ( < 0.1) 335 (18.0) 1,518 (81.5) 6 (0.3)
subtrochanteric 879 0 8 (0.9) 308 (35.0) 554 (63.0) 9 (1.0)
fnf, femoral neck fracture; imn, intramedullary nail; Ota, Orthopaedic trauma association; shs, sliding hip screw.
Table IV. hospital characteristics (2018 data).
Variable Total median (IQr)
population base in catchment area 5,300,000 82,000 (42,000 to 140,000)
Orthopaedic consultants 481 7 (5 to 17)
Orthopeadic specialist registrar/resident 284 7 (3 to 9)
Orthopaedic beds in hospital 1,053 21 (12 to 30)
hip fracture volume, 2014 to 2018 (total) 41,699 777 (444 to 1,238)
Hip fracture volume, 2014 to 2018 (included in study) 29,613 553 (309 to 892)
low (11 hospitals) 2,213 238 (83 to 276)
intermediate low (11 hospitals) 5,331 480 (450 to 533)
intermediate high (11 hospitals) 8,030 696 (615 to 862)
high (10 hospitals) 14,039 1,327 (1,018 to 1,809)
hospitals routinely treating hip fractures, n (%) 43 (100)
separate orthopaedic ward, n (%) 32 (74)
Dedicated hip fracture unit, n (%) 11 (26)
Orthogeriatric service, n (%) 14 (33)
hospital hip fracture programme, n (%) 37 (86)
24/7 service for hip fracture patients, n (%) 37 (86)
Hospital characteristics. treatment volume and organi-
zation of orthopaedic services are given in table iv. the 
majority of hospitals (74%; n = 32)) reported having a 
separate orthopaedic ward, a hospital hip fracture pro-
gramme (86%; n = 37)) and 24/7 service for hip fracture 
patients (86%; n = 37)). a dedicated hip fracture unit was 
present in 26% of the hospitals (n = 11), while an orthog-
eriatric service was present in 33% (n = 14). the hospitals 
had a median of seven orthopaedic consultants (iQR 5 to 
17) and seven specialist registrars/residents (iQR 3 to 9) 
in orthopaedic surgery. in the study period, the median 
hospital patient volume was 553 (iQR 309 to 892).
Hospital adherence to guidelines. variation in adherence 
to guideline recommendations (described in table i) re-
lated to hospital category (volume groups) has also been 
estimated and is illustrated in figure 2.
a mean 83% of patients (71% to 91%) was treated 
within 48 hours (figure 2a) and 83% of patients (65% to 
96%) were treated by an experienced surgeon (figure 2b). 
for undisplaced fnfs screw fixation was used in 86% of 
patients (51% to 99%; figure 2c).
the majority of patients (mean 96% (79% to 99%)) 
with a displaced fnf received an arthroplasty (figure 2d), 
and a mean 80% of these patients (0.3% to 100%) 
had a cemented stem. seven of the 43 hospitals used 
a cemented prosthetic stem in fewer than 40% of the 
arthroplasties in contrast to five hospitals that used bone 
cement in all patients (100%; figure 2e).
in trochanteric fractures the mean proportion 
receiving guideline- recommended treatment with 
a shs was 68% (0% to 99%; figure  2f). in inter- and 
subtrochanteric fractures, the mean proportion of 
patients treated with the recommended imn was 76% 
(9% to 100%). in 14 hospitals (33%) the mean propor-
tion receiving imn for such fractures was below 30%, 
while 16 hospitals used imn in more than 90% of 
patients (figure 2g).
the mean composite best practice indicator for the 
group of hip fractures in January 2014 to December 2018 
was 55% (figure 2h).
During the five- year study period, adherence improved 
for all fracture types, except for trochanteric fractures 
(figure 3); the mean composite "best practice indicator" 
increased from 50% (2014) to 59% (2018).
Predictors for adherence to guidelines. adherence to 
guidelines, expressed by the composite measure of 
best practice calculated for all hip fractures, is shown 
in table  v. hospitals with a dedicated hip fracture unit 
adhered more often to guidelines than those without 
such a unit (OR 1.06 (95% Ci 1.01 to 1.11); p = 0.025). 
furthermore, hospitals with a hip fracture programme 
were more compliant in following guidelines compared 
vOl. 1, nO. 10, OCtOBeR 2020
HIP FRACTURE TREATMENT IN NORWAY 649
Fig. 2
a) surgery within 48 hours. b) surgeon with more than three years of fracture surgery experience. c) undisplaced femoral neck fractures (fnfs) treated with 
screw fixation. d) Displaced fnfs treated with arthroplasty. e) arthroplasties with cemented stem. f) trochanteric aO/Ota a1 fractures treated with sliding hip 
screw (shs). g) intertrochanteric aO/Ota a3 and subtrochanteric fractures treated with intramedullary nail (imn). h) Best practice 2014 to 2018 mean values.
Fig. 3
fracture specific adherence to best practice January 2014 to December 2018. values given as mean percent adherence to fracture specific guideline 
recommendation.fnf, femoral neck fracture,Ota, Orthopaedic trauma association.
to hospitals without such a programme (OR 1.16 (95% 
Ci 1.06 to 1.27); p = 0.002). the effect of hospital treat-
ment volume on adherence to guideline recommenda-
tions expressed by the term "best practice" varied sig-
nificantly; with high volume hospitals as reference, both 
intermediate- high and low volume hospitals adhered 
significantly better to best practice (OR 1.08 (95% Ci 1.02 
to 1.14); p = 0.010, and OR 1.19 (95% Ci 1.08 to 1.31); 
p < 0.001 respectively), whereas intermediate low vol-
ume hospitals underperformed (OR 0.82 (95% Ci 0.76 to 
0.87); p < 0.001). table v also shows a gradual improve-
ment in adherence to guidelines over the period studied.
BOne & JOint Open 
C. KJAERVIK, E. STENSLAND, H. S. BYHRING, J. E. GJERTSEN, E. DYBVIK, O. SØREIDE650
Table V. factors influencing best practice.
Factor Patients, n Best practice, n (%) Or (95% CI) p- value
Orthogeriatric service
Yes 12,340 6,779 (54.9) 1.01 (0.96 to 1.06) 0.740
no 15,981 8,759 (54.8) Reference
Dedicated hip fracture unit
Yes 10,925 6,089 (55.7) 1.06 (1.01 to 1.11) 0.025
no 17,396 9,449 (54.3) Reference
Separate orthopaedic ward
Yes 24,777 13,542 (51.5) 0.94 (0.88 to 1.01) 0.086
no 3,544 1,996 (56.3) Reference
Hospital hip fracture programme
Yes 26,323 14,509 (55.1) 1.16 (1.06 to 1.27) 0.002
no 1,998 1,029 (51.5) Reference
Total hip fracture volume of hospital 2014 to 2018
high (868 to 2,025) 13,388 7,366 (55.0) Reference
intermediate high (551 to 839) 7,754 4,402 (56.8) 1.08 (1.02 to 1.14) 0.010
intermediate low (373 to 541) 5,100 2,540 (49.8) 0.82 (0.76 to 0.87) < 0.001
low volume (66 to 296) 2,079 1,230 (59.2) 1.19 (1.08 to 1.31) < 0.001
Year of surgery
2014 5,635 2,850 (50.6) Reference
2015 5,742 3,036 (52.9) 1.10 (1.02 to 1.18) 0.013
2016 5,806 3,085 (53.1) 1.11 (1.04 to 1.20) 0.004
2017 5,618 3,276 (58.3) 1.38 (1.28 to 1.49) < 0.001
2018 5,52 3,291 (59.6) 1.45 (1.35 to 1.57) < 0.001
rHa
south- eastern norway 16,347 8,692 (53.2) Reference
western norway 5,194 2,877 (55.4) 1.09 (1.03 to 1.16) 0.006
Central norway 4,150 2,594 (62.5) 1.50 (1.39 to 1.60) < 0.001
northern norway 2,630 1,375 (52.3) 0.97 (0.89 to 1.06) 0.488
Ci, confidence interval; OR, odds ratio; Rha, regional health authority.
there were also significant differences between the 
four regional health authorities (Rhas). with the most 
populated region (south- eastern norway Rha) as refer-
ence, western norway Rha and Central norway Rha 
adhered significantly better to best practice (OR 1.50 
(95% Ci 1.39 to 1.60); p < 0.001, and OR 1.09 (95% Ci 
1.03 to 1.16); p = 0.006 respectively), whereas northern 
norway Rha did not differ significantly.
Consequences of deviation from guidelines. guideline- 
recommended treatment and subsequent outcomes are 
presented in table vi. Delayed surgery exceeding the rec-
ommended 48 hours increased 365 day mortality (OR 1.13 
(95% Ci 1.05 to 1.22); p = 0.001). Years of experience of 
surgeons did not affect any of the three outcome measures. 
for undisplaced fnfs, non- adherence to the recommend-
ed screw fixation reduced the risk of reoperation substan-
tially (OR 0.34 (95% Ci 0.21 to 0.55); p < 0.001). patients 
with displaced fnf receiving treatment alternatives other 
than the recommended arthroplasty had a statistically sig-
nificantly higher 30 day mortality rate (OR 1.29 (95% Ci 
1.03 to 1.62); p = 0.030), a higher 365 day mortality rate 
(OR 1.45 (95% Ci 1.22 to 1.72); p < 0.001) and a higher 
365 day reoperation rate (OR 4.61 (95% Ci 3.73 to 5.71); 
p < 0.001). patients treated with arthroplasty without the 
recommended cemented stem had a statistically significant 
higher 365 day reoperation rate (OR 1.23 (95% Ci 1.02 to 
1.48); p = 0.030). patients with trochanteric fractures not 
treated with the recommended shs had a significantly low-
er 365 day mortality rate (OR 0.85 (95% Ci 0.75 to 0.98); p 
= 0.023). for inter- and subtrochanteric fractures the risk of 
reoperation increased significantly if recommended treat-
ment with imn was not employed (OR 1.54 (95% Ci 1.10 
to 2.16); p = 0.012).
Discussion
Our study demonstrates substantial hospital variation in 
adherence to evidence- based guidelines used for treat-
ment of hip fractures in norway. further findings are that 
best practice can be ascribed to in- hospital factors and 
that the variation has significant negative consequences 
for patients in the form of increased mortality rates at 
30- and 365- day post- treatment and in reoperation rates. 
On the other hand, adherence, expressed by the term 
best practice, improved significantly over the five- year 
study period for all fracture types except for trochanteric 
fractures. treatment variation and non- adherence were 
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Table VI. treatment outcome according to seven guideline recommendations and according to the best practice.
mortality 30 days mortality 365 days revision 365 days
Outcome Total n (%)
Or
(95% CI) p- value n (%)
Or
(95% CI) p- value n (%)
Or
(95% CI) p- value
Surgery within 48 hours
Yes 23,390 1,969 (8.4) Reference 5,860 (25.1) Reference 1,168 
(5.0)
Reference
no 4,931 477 (9.7) 1.04 (0.93 to 
1.16)
0.499 1,427 (28.9) 1.13 (1.05 to 
1.22)
0.001 262 (5.3) 1.06 (0.92 to 
1.22)
0.405
Surgeon has > 3 years 
experience
Yes 23,815 2065 (8.7) Reference 6,091(25.8) Reference 1,171 
(5.0)
Reference
no 4,686 381 (8.1) 0.97 (0.86 to 
1.09)
0.573 1,196 (25.5) 1.04 (0.96 to 
1.12)
0.380 259 (5.5) 1.12 (0.98 to 
1.29)
0.100
Screw fixation (Garden 1 
to 2)
Yes 3,747 224 (6.0) Reference 846 (22.6) Reference 338 (9.0) Reference
no 589 46 (7.8) 1.09 (0.77 to 
1.55)
0.619 160 (27.2 ) 1.05 (0.84 to 
1.29)
0.687 19 (3.2) 0.34 (0.21 to 
0.55) <0.001
arthroplasty (Garden 3 to 4)
Yes 16,219 1,328 (8.2) Reference 3,805 (23.5) Reference 678 (4,2) Reference
no 770 111 (14.4) 1.29 (1.03 to 
1.62)
0.030 276 (35.8) 1.45 (1.22 to 
1.72) <0.001
124 (16,1) 4.61 (3.73 to 
5.71) <0.001
Cemented stem if 
arthroplasty
Yes 13,017 1,097 (8.4) Reference 3,128 (24.0) Reference 523 (4.0) Reference
no 3,202 231 (7.2) 0.90 (0.77 to 
1.05)
0.184 677 (21.1) 0.91 (0.83 to 
1.01)
0.082 155 (4.8) 1.23 (1.02 to 
1.48)
0.030
SHS (Trochanteric aO/OTa 
a1)
Yes 3,783 348 (9.2) Reference 1,091 (28.8) Reference 96 (2.5) Reference
no 1,763 167 (9.5) 1.04 (0.85 to 
1.27)
0.701 462 (26.2) 0.85 (0.75 to 
0.98)





Yes 2,072 173 (8.4) Reference 506 (24.4) Reference 113 (5.5) Reference
no 670 67 (10.0) 1.14 (0.84 to 
1.56) 0.400
189 (28.2) 1.17 (0.95 to 
1.45) 0.139
54 (8.1) 1.54 (1.10 to 
2.16) 0.012
*logistic regression analysis.
Ci, confidence interval; imn, intramedullary nail; OR, odds ratio; Ota, Orthopaedic trauma association; shs, sliding hip screw.
notable although 86% of hospitals (n = 37) reported that 
they had a local, hospital- based, hip fracture programme.
we acknowledge that it is good medical practice to 
deviate from guidelines in specific clinical settings, if devi-
ation can be substantiated. however, although the non- 
adherence rates demonstrated in this study may appear 
not to be substantial, deviation still represents a signifi-
cant number of patients receiving less- than- optimal treat-
ment. as an example, an adherence rate of 80% in the 
use of a cemented hip prosthesis means that more than 
3,000 patients in norway in the five year study period did 
not receive optimal care. we argue that deviation cannot 
be explained by rational clinical judgment alone, partic-
ularly because we have excluded combined (complex) 
fractures where variation and treatment according to 
surgeon discretion could be expected.
evidence- based guidelines are in principle valid at the 
time of publication and must be revised when significant 
new scientific data have accrued. an example of this is 
that the sign guideline has now been withdrawn for revi-
sion. we would argue that there has been no paradigm 
shift in hip fracture treatment policies over the five- year 
study period, which may explain the relatively high non- 
adherence rates.
a striking feature is that individual hospitals did 
comply with guidelines for some items (time of surgery, 
competence) and fracture types, but at the same time 
demonstrated significant non- adherence and deviation 
for others. this explains the relatively low adherence rate 
when all hip fractures were evaluated as a group. further, 
some hospitals were at odds with long- established and 
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scientifically strong evidence. an example of this is the 
use of uncemented prosthesis stems.17
non- adherence to guidelines is not a unique norwe-
gian phenomenon. a Dutch study showed that 74% of 
treatment for fnf complied with established national 
guidelines.18 they did not study structural components 
of care nor geographical variation in adherence. Data 
from the British national hip fracture Database also have 
shown wide disparities and poor adherence to guidelines 
in the use of total hip arthroplasty for hip fractures.19 
inconsistent compliance with guidelines poses a signifi-
cant risk of inequality in treatment and poor outcomes.
Consequently, our findings strongly suggest that the 
observed variation mostly depends on providers and 
their hospital- specific, probably unwritten, treatment 
preferences. a hospital “surgical signature”, as described 
by Birkmeyer et al,20 probably reflects hospital- specific 
traditions due to regional training and surgeon- specific 
attitudes and beliefs as to treatment policy, which over-
ride established scientific evidence and formal national 
guidelines. Bhandari and swiontkowski2 have also shown 
that surgeons disagree on the optimal treatment prin-
ciple (arthroplasty or internal fixation) in patients aged 
60 to 80 years with fnf and that surgeons' personal pref-
erences and beliefs probably have a major impact on the 
choice of treatment.
it is a challenge to explain the treatment volume and 
regional effects on adherence to best practice in a logical 
or clinical context. some of the effects may be explained 
by an uneven distribution of hospitals favouring a non- 
cemented prosthesis stem in volume groups and regional 
categories. Certain structural elements of the hospitals 
may also contribute. Considering all information as a 
whole, we conclude that treatment practice in individual 
hospitals is the main cause of non- adherence.
grove et al21 have explored different drivers of varia-
tion in orthopaedic surgery. they argued that formal 
codified knowledge such as evidence- based guidelines 
has a little influence on decision- making. they concluded 
that treatment decisions are more driven by socialized 
knowledge spread between colleagues, particularly 
influenced by professional meetings and conferences.21 
timmermans22 also emphasizes the importance of clin-
ical autonomy, which takes precedence over guidelines. 
surgeon autonomy and informal paths of knowledge 
may partly explain the marked variation in adherence.
the main strength of this study is that it is population- 
based with a high inclusion rate and a high degree of 
completeness of the data from the nhfR. Reports to 
the registry are completed directly after surgery, which 
ensures high accuracy of the information. subse-
quently, the nhfR provides high- quality information 
on hip fracture treatment in norway.
a limitation is that there has been an underreporting 
of reoperations in the nhfR.4 Reporting of reoperations 
probably does not differ between fracture groups. 
therefore, more complete data would probably have 
supported and strengthened our findings, particularly 
the effects on outcomes (table vi). we also acknowledge 
that the use of the asa grade to express preoperative 
physical status may not fully characterize health status 
of this patient group. On the other hand, we argue that 
adjustment for health status of the patients using the 
asa grade is far better than no adjustment at all. there 
may also be factors other than the variables included 
in this study that may influence the choice of treat-
ment, and that may legitimize a treatment deviating 
from guideline recommendations.we acknowledge 
that concluding summary treatment recommenda-
tions based on five evidence- based guidelines might be 
challenged. however, we would argue that the recom-
mendations summarized in table i were homogeneous 
across the guidelines and that the discrepancies we 
encountered were of minor importance.
there is substantial variation in the treatment of 
hip fractures in norway. adherence to guidelines has 
gradually improved over the five- year study period, 
but in 2018 only 59% of patients received best prac-
tice treatment. non- adherence had a negative effect on 
patient outcomes. steps must be taken to disseminate 
knowledge on best practice and consequences of non- 
adherence, and to improve non- compliance and reduce 
the importance of surgeons’ personal preferences in 
treatment decisions.
Take home message
  - Substantial variation in hip fracture treatment in Norway, 
despite established evidence- based guidelines.
  - Deviation from best practice has negative consequences for 
patient outcomes.
  - Dissemination of information on best practice through guidelines is 
challenging.
Twitter
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